Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,562 | 551 | 99.0% |
| Education | $102.90 | 5 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,383 | 64 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,049 | 59 | $0 (2022) |
| PFIZER INC. | $843.39 | 41 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $789.42 | 45 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $692.19 | 30 | $0 (2022) |
| Lilly USA, LLC | $685.31 | 42 | $0 (2024) |
| GlaxoSmithKline, LLC. | $634.21 | 32 | $0 (2024) |
| Amgen Inc. | $537.01 | 28 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $447.32 | 21 | $0 (2023) |
| ABBVIE INC. | $409.39 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $137.47 | 6 | GlaxoSmithKline, LLC. ($37.81) |
| 2023 | $641.50 | 32 | Lilly USA, LLC ($155.11) |
| 2022 | $1,526 | 84 | Novo Nordisk Inc ($282.28) |
| 2021 | $2,473 | 146 | Novo Nordisk Inc ($346.63) |
| 2020 | $2,158 | 122 | AstraZeneca Pharmaceuticals LP ($223.53) |
| 2019 | $1,739 | 80 | AstraZeneca Pharmaceuticals LP ($333.84) |
| 2018 | $1,341 | 67 | AstraZeneca Pharmaceuticals LP ($364.18) |
| 2017 | $649.18 | 19 | PFIZER INC. ($362.64) |
All Payment Transactions
556 individual payment records from CMS Open Payments — Page 23 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: RESPIRATORY | ||||||
| 08/31/2017 | GlaxoSmithKline, LLC. | INCRUSE (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2017 | Astellas Pharma US Inc | Myrbetriq (Drug), Vesicare | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Urology | ||||||
| 08/01/2017 | Arbor Pharmaceuticals, Inc. | Edarbyclor (Drug) | Food and Beverage | Cash or cash equivalent | $11.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/21/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2017 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $118.74 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 292 | 428 | $52,535 | $22,082 |
| 2022 | 7 | 304 | 491 | $62,369 | $26,902 |
| 2021 | 5 | 164 | 236 | $36,059 | $15,653 |
| 2020 | 9 | 256 | 401 | $68,044 | $28,234 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 171 | $37,421 | $14,816 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $5,101 | $2,959 | 58.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 33 | $5,156 | $2,232 | 43.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 41 | 41 | $1,469 | $742.51 | 50.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 65 | 95 | $696.00 | $611.52 | 87.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 32 | 47 | $1,880 | $531.75 | 28.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 18 | $811.60 | $189.55 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 203 | $42,360 | $17,947 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 36 | 36 | $7,920 | $4,705 | 59.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 34 | $3,309 | $1,886 | 57.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 41 | 57 | $2,280 | $884.04 | 38.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,555 | $863.32 | 19.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 77 | 124 | $744.00 | $366.87 | 49.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 23 | $1,201 | $250.27 | 20.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 143 | $29,840 | $11,952 | 40.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 19 | 19 | $4,180 | $2,542 | 60.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,265 | $815.43 | 64.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 11 | 12 | $480.00 | $196.71 | 41.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 39 | 49 | $294.00 | $147.00 | 50.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 146 | $30,466 | $10,858 | 35.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 23 | 48 | $6,456 | $3,925 | 60.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 27 | 65 | $9,186 | $3,811 | 41.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 16 | 17 | $6,800 | $2,941 | 43.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 38 | $3,810 | $1,978 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 15 | 15 | $3,300 | $1,751 | 53.1% |
About Dr. Daniel Eckstein, M.D
Dr. Daniel Eckstein, M.D is a Family Medicine healthcare provider based in St Petersburg, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1366704843.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Eckstein, M.D has received a total of $10,665 in payments from pharmaceutical and medical device companies, with $137.47 received in 2024. These payments were reported across 556 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($10,562).
As a Medicare-enrolled provider, Eckstein has provided services to 1,016 Medicare beneficiaries, totaling 1,556 services with total Medicare billing of $92,870. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location St Petersburg, FL
- Active Since 06/11/2012
- Last Updated 06/20/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1366704843
Products in Payments
- Ozempic (Drug) $694.01
- FARXIGA (Drug) $652.85
- XARELTO (Drug) $581.43
- TRELEGY ELLIPTA (Drug) $545.27
- JARDIANCE (Drug) $497.21
- ELIQUIS (Drug) $422.86
- NURTEC ODT (Drug) $390.93
- TRULICITY (Drug) $318.83
- VRAYLAR (Drug) $247.74
- Aimovig (Biological) $247.09
- UBRELVY (Drug) $243.27
- INJECTAFER (Drug) $240.99
- EMGALITY (Drug) $239.21
- TRINTELLIX (Drug) $224.95
- Tresiba (Drug) $217.75
- ADAKVEO (Biological) $196.59
- ENTRESTO (Drug) $189.02
- INVOKANA (Drug) $184.74
- SYMBICORT (Drug) $173.82
- XIFAXAN (Drug) $168.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in St Petersburg
Edward Braun, Md, MD
Family Medicine — Payments: $329,209
Dr. Roxana Stoici, Md, MD
Family Medicine — Payments: $228,936
Dr. Robert Wallace, Md, MD
Family Medicine — Payments: $151,311
Dr. Frederic Guerrier, M.d, M.D
Family Medicine — Payments: $45,706
Dr. Gigi Lefebvre, Md, MD
Family Medicine — Payments: $15,802
Dr. Kunal Amin, Md, MD
Family Medicine — Payments: $10,623